Skip to content

    TriSalus Life Sciences (TLSI) stock price & financials

    View TLSI earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance5.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $7.35M
    $8.26M
    $9.17M
    $11.21M
    $11.57M
    +57.4%
    $13.21M
    +59.8%
    $8.90M
    -2.9%
    $11.41M
    +1.7%
    Strengthening
    Operating Profit
    -$8.74M
    -$7.58M
    -$7.33M
    -$7.33M
    -$9.01M
    -3.1%
    -$3.27M
    +56.8%
    -$8.41M
    -14.8%
    -$9.81M
    -33.8%
    Stable
    Net Profit
    -$2.40M
    -$10.11M
    -$10.38M
    -$8.29M
    -$10.81M
    -350.6%
    -$9.75M
    +3.5%
    $1.54M
    -$9.19M
    -10.8%
    Weakening
    EPS
    $-0.12
    $-0.39
    $-0.27
    $-0.96
    -700.0%
    $0.03
    $-0.16
    +40.7%
    Strengthening
    Other Income
    Interest
    $1.14M
    $1.07M
    $1.21M
    $1.42M
    $1.46M
    +27.8%
    $1.45M
    +36.0%
    $1.44M
    +18.8%
    $1.49M
    +4.7%
    Strengthening
    Depreciation
    Profit before Tax
    -$2.40M
    -$10.11M
    -$10.37M
    -$8.29M
    -$10.81M
    -349.9%
    -$9.75M
    +3.5%
    $1.54M
    -$9.18M
    -10.8%
    Weakening
    MarginsOPM
    -118.9%
    -91.8%
    -80.0%
    -65.4%
    -77.9%
    +34.5%
    -24.8%
    +73.0%
    -94.5%
    -18.2%
    -86.0%
    -31.6%
    Strengthening
    Tax
    0.1%
    0.0%
    -0.1%
    0.0%
    -0.1%
    -141.7%
    0.0%
    -100.0%
    0.3%
    -0.0%
    -200.0%
    Weakening
    ReturnsROIC
    0.7%
    3.0%
    3.1%
    2.5%
    3.2%
    +350.6%
    2.9%
    -3.5%
    -0.5%
    -114.8%
    2.7%
    +10.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$200.9K$9.41M$11.78M$8.53M$20.44M$46.29M
    Short-Term Investments
    Total Current Assets$525.9K$17.21M$20.86M$20.67M$32.24M$59.74M
    Net PP&E$3.61M$3.27M$2.88M$2.67M$2.63M
    Goodwill
    Intangibles$802.0K$0
    Total Assets$250.53M$22.00M$24.60M$23.97M$35.33M$62.45M
    LiabilitiesTotal Current Liabilities$1.60M$32.36M$14.69M$10.23M$11.50M$11.17M
    Short-Term Debt
    Long-Term Debt$0$22.08M$33.05M$33.06M
    Long-Term Leases$1.16M$1.31M$1.19M
    Total Liabilities$17.25M$34.32M$51.66M$49.87M$69.19M$55.90M
    EquityCommon Stock & APIC$0$2.0K$3.0K$4.0K$5.0K
    Retained Earnings-$16.72M-$186.36M-$249.50M-$279.55M-$330.58M-$338.23M
    Total Equity-$129.60M-$177.13M-$27.07M-$25.89M-$33.86M$6.55M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$1.74M-$32.31M-$50.58M-$40.84M-$18.01M-$22.80M
    Cash from Investing$60.0K-$1.79M-$1.59M-$345.0K-$838.0K-$440.0K
    Cash from Financing$544.0K$13.46M$54.63M$37.94M$30.76M$42.69M
    SummaryCapital Expenditure-$655.0K-$588.0K-$345.0K-$918.0K-$480.0K
    Free Cash Flow-$32.97M-$51.17M-$41.19M-$18.93M-$23.28M
    FCF Margin-265.9%-276.4%-139.9%-41.9%-51.6%

    Ratios